---
title: Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
nct_id: NCT05708820
overall_status: UNKNOWN
phase: NA
sponsor: Hospital Mutua de Terrassa
study_type: INTERVENTIONAL
primary_condition: Diabetes Mellitus, Type I
countries: Spain
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05708820.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05708820"
ct_last_update_post_date: 2023-02-01
last_seen_at: "2026-05-12T06:56:12.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control

**NCT ID:** [NCT05708820](https://clinicaltrials.gov/study/NCT05708820)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** Hospital Mutua de Terrassa
- **Conditions:** Diabetes Mellitus, Type I
- **Start Date:** 2022-12-14
- **Completion Date:** 2024-07-31
- **CT.gov Last Update:** 2023-02-01

## Brief Summary

The aim of this study is to evaluate the effectiveness of an online intervention for people with type 1 diabetes who present not optimal control of the disease.

## Detailed Description

Study area: adults with type 1 diabetes, HbA1c \>7.5%, \>3 years diagnosed. Methods: randomized clinical trial. It will include 60 participants . The improvement of Glycated Haemoglobin in both groups before and after intervention will be compared; adherence to the treatment, quality of life, time in the glycaemic range, perception of hypoglycaemia and knowledge about diabetes.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* HbA1c ≥7,5%
* More than 3 years of diagnosis
* Ability to follow online sessions
* Having a device to follow up the education programme

Exclusion Criteria:

* Pregnants
* People on corticosteroid treatment
* People with severe disease
* People with continuous subcutaneous insulin infusion (CSII)
```

## Arms

- **Standard care** (ACTIVE_COMPARATOR) — Group in face-to-face session
- **Online education programme** (EXPERIMENTAL) — Group in online sessions

## Interventions

- **Online education programme** (BEHAVIORAL) — Online group will follow the education programme through videos that they can view at any time and a live session to answer questions.
- **Standard education programme** (BEHAVIORAL) — Face-to-face educacion programme in a group session

## Primary Outcomes

- **HbA1c** _(time frame: Change from Baseline at 12 months)_ — glycosylated hemoglobin

## Secondary Outcomes

- **Time in Range (TIR)** _(time frame: Change from Baseline at 12 months)_
- **Knowledge related to diabetes management** _(time frame: Change from Baseline at 12 months)_
- **Awareness of hypoglycemia** _(time frame: Change from Baseline at 12 months)_

## Locations (2)

- Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain — _RECRUITING_
- Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.hospital mutua de terrassa|terrassa|barcelona|spain` — added _(2026-05-12)_
- `locations.hospital universitari mútua de terrassa|terrassa|barcelona|spain` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05708820.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05708820*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*